Vimarsana
Biggest News Aggregation in the World

David Lamond News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Lamond. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Lamond Today - Breaking & Trending Today

Sydney Harbour Regatta entries top 100 as prizes revealed - Vimarsana News

Sydney Harbour Regatta entries top 100 as prizes revealed

Entries to the 2024 Nautilus Marine Insurance Sydney Harbour Regatta have topped 100 and continue growing daily as Middle Harbour Yacht Club (MHYC)

Quince Therapeutics, Inc. (NASDAQ:QNCX) Director Buys $22,773.54 in Stock - Vimarsana News

Quince Therapeutics, Inc. (NASDAQ:QNCX) Director Buys $22,773.54 in Stock

Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) Director David Lamond bought 22,327 shares of the company’s stock in a transaction on Tuesday, December 12th. The stock was bought at an average price of $1.02 per share, for a total transaction of $22,773.54. Following the completion of the purchase, the director now directly owns 2,302,291 […]

Source: wkrb13.com
Why Are Cities Closing Shelters If Homelessness Is Rising? - Vimarsana News

Why Are Cities Closing Shelters If Homelessness Is Rising?

In Pittsburgh, people sleep outside the doors of a fully occupied facility

Source: wsj.com
Quince Therapeutics, Inc. (NASDAQ:QNCX) Director David Lamond Purchases 19,123 Shares - Vimarsana News

Quince Therapeutics, Inc. (NASDAQ:QNCX) Director David Lamond Purchases 19,123 Shares

Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) Director David Lamond bought 19,123 shares of the firm’s stock in a transaction on Tuesday, December 5th. The shares were purchased at an average cost of $1.01 per share, with a total value of $19,314.23. Following the completion of the transaction, the director now owns 2,241,418 shares […]

Insider Buying: Quince Therapeutics, Inc. (NASDAQ:QNCX) Director Purchases 19,123 Shares of Stock - Vimarsana News

Insider Buying: Quince Therapeutics, Inc. (NASDAQ:QNCX) Director Purchases 19,123 Shares of Stock

Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) Director David Lamond bought 19,123 shares of the stock in a transaction on Thursday, December 7th. The stock was purchased at an average price of $1.01 per share, with a total value of $19,314.23. Following the completion of the acquisition, the director now directly owns 2,279,664 shares […]